Stock Analysts’ updated eps estimates for Wednesday, January 11th:

Barrick Gold Corporation (NYSE:ABX) (TSE:ABX) had its hold rating reiterated by analysts at Barclays PLC. The firm currently has a $20.00 price target on the stock.

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its buy rating reiterated by analysts at J P Morgan Chase & Co.

This article was originally published by and is the sole property of American Banking News. If you happen to be reading this article on another website, it was stolen and illegally republished in violation of U.S. and International copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/01/11/stock-analysts-updated-eps-estimates-for-january-11th-abx-acad-acia-amrs-arrs-auy-azn-bfam-bta-caa-2.html

Acacia Communications (NASDAQ:ACIA) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $125.00 price target on the stock.

Amyris (NASDAQ:AMRS) had its buy rating reiterated by analysts at Rodman & Renshaw. The firm currently has a $4.00 price target on the stock.

ARRIS International PLC (NASDAQ:ARRS) had its buy rating reiterated by analysts at Barclays PLC. They currently have a $37.00 price target on the stock.

Yamana Gold (NYSE:AUY) (TSE:YRI) had its hold rating reiterated by analysts at Barclays PLC. They currently have a $4.00 target price on the stock.

AstraZeneca plc (LON:AZN) had its underperform rating reaffirmed by analysts at Credit Suisse Group. They currently have a GBX 4,000 ($48.64) price target on the stock.

Bright Horizons Family Solutions (NYSE:BFAM) had its buy rating reaffirmed by analysts at Barclays PLC. Barclays PLC currently has a $80.00 price target on the stock.

BlackRock LT Municipal Advantage Trust (NYSE:BTA) had its overweight rating reiterated by analysts at Morgan Stanley. The firm currently has a GBX 490 ($5.96) target price on the stock.

CalAtlantic Group (NYSE:CAA) had its buy rating reissued by analysts at MKM Partners.

CEVA (NASDAQ:CEVA) had its buy rating reaffirmed by analysts at Barclays PLC. They currently have a $40.00 target price on the stock.

Cineworld Group plc (LON:CINE) had its hold rating reiterated by analysts at Canaccord Genuity. They currently have a GBX 550 ($6.69) target price on the stock.

Chipotle Mexican Grill (NYSE:CMG) had its buy rating reaffirmed by analysts at Buckingham Research. The firm currently has a $547.00 price target on the stock.

Chipotle Mexican Grill (NYSE:CMG) had its neutral rating reiterated by analysts at BTIG Research.

CVR Refining, (NYSE:CVRR) had its sell rating reiterated by analysts at Barclays PLC. They currently have a $10.00 target price on the stock.

Dana (NYSE:DAN) had its buy rating reaffirmed by analysts at Barclays PLC. Barclays PLC currently has a $22.00 price target on the stock.

Diplomat Pharmacy (NYSE:DPLO) had its market perform rating reiterated by analysts at Cowen and Company. Cowen and Company currently has a $14.00 price target on the stock, down from their previous price target of $18.00.

Express (NYSE:EXPR) had its buy rating reiterated by analysts at Mizuho. They currently have a $13.00 price target on the stock.

Facebook (NASDAQ:FB) had its outperform rating reaffirmed by analysts at Credit Suisse Group. Credit Suisse Group currently has a $165.00 price target on the stock, down from their previous price target of $170.00.

Franco-Nevada Corporation (NYSE:FNV) (TSE:FNV) had its hold rating reaffirmed by analysts at Barclays PLC. They currently have a $65.00 target price on the stock.

Gildan Activewear (NYSE:GIL) (TSE:GIL) had its hold rating reaffirmed by analysts at Brean Capital.

GKN plc (LON:GKN) had its buy rating reaffirmed by analysts at Bank of America Corporation. Bank of America Corporation currently has a GBX 365 ($4.44) target price on the stock.

GoPro (NASDAQ:GPRO) had its hold rating reissued by analysts at Barclays PLC. They currently have a $10.00 price target on the stock.

Hawaiian Holdings (NASDAQ:HA) had its outperform rating reaffirmed by analysts at Imperial Capital. Imperial Capital currently has a $70.00 target price on the stock.

Hanesbrands (NYSE:HBI) had its buy rating reissued by analysts at Brean Capital.

HollyFrontier Corporation (NYSE:HFC) had its buy rating reaffirmed by analysts at Barclays PLC. Barclays PLC currently has a $41.00 target price on the stock.

Integra LifeSciences Holdings Corporation (NASDAQ:IART) had its buy rating reiterated by analysts at Oppenheimer Holdings, Inc..

Illumina (NASDAQ:ILMN) had its outperform rating reaffirmed by analysts at Cowen and Company. Cowen and Company currently has a $150.00 target price on the stock.

Juno Therapeutics (NASDAQ:JUNO) had its hold rating reissued by analysts at J P Morgan Chase & Co.

KB Home (NYSE:KBH) had its outperform rating reiterated by analysts at Wedbush. They currently have a $22.00 price target on the stock.

K2M Group Holdings (NASDAQ:KTWO) had its buy rating reaffirmed by analysts at Barclays PLC. They currently have a $26.00 price target on the stock.

J P Morgan Chase & Co initiated coverage on shares of LATAM Airlines Group (NYSE:LFL). J P Morgan Chase & Co issued a hold rating and a $10.00 target price on the stock.

lululemon athletica inc. (NASDAQ:LULU) had its buy rating reiterated by analysts at Robert W. Baird.

Mellanox Technologies (NASDAQ:MLNX) had its buy rating reiterated by analysts at Barclays PLC. Barclays PLC currently has a $55.00 target price on the stock.

Merck & Company (NYSE:MRK) had its buy rating reiterated by analysts at J P Morgan Chase & Co.

Micron Technology (NASDAQ:MU) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $33.00 target price on the stock.

National Express Group PLC (LON:NEX) had its buy rating reaffirmed by analysts at Canaccord Genuity. Canaccord Genuity currently has a GBX 432 ($5.25) target price on the stock.

Universal Display Corporation (NASDAQ:OLED) had its hold rating reiterated by analysts at Needham & Company LLC.

Petrofac Limited (LON:PFC) had its outperform rating reaffirmed by analysts at Credit Suisse Group. Credit Suisse Group currently has a GBX 1,100 ($13.38) target price on the stock.

IMPINJ (NYSE:PI) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $32.00 price target on the stock.

Regeneron Pharmaceuticals (NASDAQ:REGN) had its market perform rating reiterated by analysts at Cowen and Company. Cowen and Company currently has a $380.00 price target on the stock, down from their previous price target of $400.00.

Shoe Carnival (NASDAQ:SCVL) had its hold rating reaffirmed by analysts at Jefferies Group. They currently have a $26.00 target price on the stock, down from their previous target price of $28.00.

Silicon Motion Technology Corporation (NASDAQ:SIMO) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $60.00 price target on the stock.

Sarepta Therapeutics (NASDAQ:SRPT) had its hold rating reaffirmed by analysts at Jefferies Group.

Sanford C. Bernstein assumed coverage on shares of Tencent Holding (OTCMKTS:TCEHY). They issued a hold rating on the stock.

Thomas Cook Group plc (LON:TCG) had its neutral rating reiterated by analysts at Credit Suisse Group. They currently have a GBX 88 ($1.07) target price on the stock.

Toll Brothers (NYSE:TOL) had its buy rating reaffirmed by analysts at MKM Partners.

UBM Plc (LON:UBM) had its neutral rating reiterated by analysts at Credit Suisse Group. Credit Suisse Group currently has a GBX 800 ($9.73) target price on the stock.

Valero Energy Corporation (NYSE:VLO) had its buy rating reiterated by analysts at Barclays PLC. Barclays PLC currently has a $95.00 price target on the stock.

Vodafone Group PLC (NASDAQ:VOD) had its neutral rating reiterated by analysts at J P Morgan Chase & Co.

Valeant Pharmaceuticals International (NYSE:VRX) (TSE:VRX) had its neutral rating reissued by analysts at BTIG Research.

WageWorks (NYSE:WAGE) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $74.00 target price on the stock.

Intersect ENT (NASDAQ:XENT) had its outperform rating reiterated by analysts at Wedbush. Wedbush currently has a $25.00 target price on the stock.

Receive News & Ratings for Barrick Gold Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Barrick Gold Corporation and related companies with MarketBeat.com's FREE daily email newsletter.